Visnja Fink Selected Research

Visnja Fink Research Topics

20	Breast Neoplasms (Breast Cancer) 12/2023 - 06/2015
15	Neoplasms (Cancer) 12/2023 - 06/2015
3	Fatigue 12/2020 - 06/2016
2	Circulating Neoplastic Cells 01/2023 - 01/2018
2	Vomiting 04/2017 - 06/2016
2	Nausea 04/2017 - 06/2016
1	Overweight 01/2023
1	Obesity 01/2023
1	Weight Gain 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Neoplasm Metastasis (Metastasis) 05/2022
1	Pain (Aches) 08/2021
1	Arthralgia (Joint Pain) 08/2021
1	Anemia 12/2020
1	Leukopenia 12/2020
1	Amenorrhea 10/2019
1	Residual Neoplasm 01/2018
1	Seroma 10/2016
1	Carcinoma (Carcinomatosis) 06/2014
1	Cicatrix (Scar) 06/2014
1	Ovarian Neoplasms (Ovarian Cancer) 06/2014

5	Hormones (Hormone)IBA 12/2023 - 06/2015
4	Docetaxel (Taxotere)FDA Link 12/2020 - 06/2016
3	Epirubicin (Ellence)FDA LinkGeneric 12/2020 - 06/2016
3	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 06/2016
3	AnthracyclinesIBA 10/2020 - 04/2017
2	Phenobarbital (Luminal)FDA Link 12/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2018
2	Gemcitabine FDA Link 10/2020 - 06/2019
2	Taxoids (Taxanes)IBA 10/2020 - 06/2019
2	taxaneIBA 06/2019 - 04/2017
1	ribociclibIBA 11/2023
1	olaparibIBA 07/2023
1	Estrogen ReceptorsIBA 03/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2022
1	Diphosphonates (Bisphosphonates)IBA 08/2021
1	Zoledronic Acid (Zometa)FDA Link 08/2021
1	Epoetin Alfa (Epogen)FDA Link 12/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	human ERBB2 proteinIBA 07/2015
1	Trastuzumab (Herceptin)FDA Link 07/2015

15	Drug Therapy (Chemotherapy) 12/2023 - 06/2015
7	Therapeutics 12/2023 - 07/2015
7	Adjuvant Chemotherapy 07/2023 - 04/2017
3	Radiotherapy 01/2018 - 06/2015
2	Mastectomy (Mammectomy) 12/2023 - 06/2014
2	Segmental Mastectomy (Lumpectomy) 01/2018 - 10/2016
1	Neoadjuvant Therapy 11/2023
1	Duration of Therapy 08/2021
1	Prophylactic Mastectomy 06/2014
1	Mammaplasty (Breast Reconstruction) 06/2014
1	Salpingo-oophorectomy 06/2014